Filed: 5/15/2025ACC: 0001697013-25-000005
📋 What this filing means
EVERSEPT PARTNERS, LP filed this quarterly 13F‑HR report disclosing 56 equity positions with a total reported market value of $984.66M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
56
Positions
$984.66M
Total AUM (reported)
48.26M
Total Shares
Allocation by class
COM$652.63M66.3%
SPONSORED ADR$101.62M10.3%
UNIT SER 1$69.21M7.0%
CL A$59.73M6.1%
TR UNIT$43.02M4.4%
COM NEW$22.57M2.3%
SPONSORED ADS$21.68M2.2%
Portfolio Concentration
Top 3$297.22M30.2%
4–10$285.51M29.0%
11–25$289.35M29.4%
Rest$112.58M11.4%
Top 3 weight
30.2%
Top 10 weight
59.2%
Voting Authority Distribution
Total shares with voting rights: 48.26M
Sole
Full voting authority
48.26M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole56
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings56
Rows:
NATERA INC
SOLEShares893.72K
TypeSH
Market value$126.38M
12.83%
Sole
893.72K
Shared
0.00
None
0.00
GSK PLC
SOLEShares2.62M
TypeSH
Market value$101.62M
10.32%
Sole
2.62M
Shared
0.00
None
0.00
INVESCO QQQ TR
SOLEShares147.60K
TypeSH
Market value$69.21M
7.03%
Sole
147.60K
Shared
0.00
None
0.00
HCA HEALTHCARE INC
SOLEShares152.50K
TypeSH
Market value$52.70M
5.35%
Sole
152.50K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares4.21M
TypeSH
Market value$51.75M
5.26%
Sole
4.21M
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares1.90M
TypeSH
Market value$45.61M
4.63%
Sole
1.90M
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares76.90K
TypeSH
Market value$43.02M
4.37%
Sole
76.90K
Shared
0.00
None
0.00
REVVITY INC
SOLEShares299.09K
TypeSH
Market value$31.64M
3.21%
Sole
299.09K
Shared
0.00
None
0.00
HEALTHEQUITY INC
SOLEShares351.98K
TypeSH
Market value$31.10M
3.16%
Sole
351.98K
Shared
0.00
None
0.00
INSPIRE MED SYS INC
SOLEShares186.43K
TypeSH
Market value$29.69M
3.02%
Sole
186.43K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares547.12K
TypeSH
Market value$26.46M
2.69%
Sole
547.12K
Shared
0.00
None
0.00
COMMUNITY HEALTH SYS INC NEW
SOLEShares8.46M
TypeSH
Market value$22.84M
2.32%
Sole
8.46M
Shared
0.00
None
0.00
ZIMVIE INC
SOLEShares2.08M
TypeSH
Market value$22.46M
2.28%
Sole
2.08M
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares1.41M
TypeSH
Market value$21.68M
2.20%
Sole
1.41M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares557.07K
TypeSH
Market value$21.03M
2.14%
Sole
557.07K
Shared
0.00
None
0.00
BRUKER CORP
SOLEShares499.21K
TypeSH
Market value$20.84M
2.12%
Sole
499.21K
Shared
0.00
None
0.00
CENTENE CORP DEL
SOLEShares340.34K
TypeSH
Market value$20.66M
2.10%
Sole
340.34K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares1.38M
TypeSH
Market value$18.57M
1.89%
Sole
1.38M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares167.24K
TypeSH
Market value$18.50M
1.88%
Sole
167.24K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares57.49K
TypeSH
Market value$17.72M
1.80%
Sole
57.49K
Shared
0.00
None
0.00
BIO-TECHNE CORP
SOLEShares280.12K
TypeSH
Market value$16.42M
1.67%
Sole
280.12K
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares2.17M
TypeSH
Market value$16.29M
1.65%
Sole
2.17M
Shared
0.00
None
0.00
GLAUKOS CORP
SOLEShares158.96K
TypeSH
Market value$15.64M
1.59%
Sole
158.96K
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares517.02K
TypeSH
Market value$15.60M
1.58%
Sole
517.02K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares816.25K
TypeSH
Market value$14.63M
1.49%
Sole
816.25K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NATERA INCSOLE | COM | 893.72K | SH | $126.38M 12.83% | 893.72K | 0.00 | 0.00 |
GSK PLCSOLE | SPONSORED ADR | 2.62M | SH | $101.62M 10.32% | 2.62M | 0.00 | 0.00 |
INVESCO QQQ TRSOLE | UNIT SER 1 | 147.60K | SH | $69.21M 7.03% | 147.60K | 0.00 | 0.00 |
HCA HEALTHCARE INCSOLE | COM | 152.50K | SH | $52.70M 5.35% | 152.50K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 4.21M | SH | $51.75M 5.26% | 4.21M | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 1.90M | SH | $45.61M 4.63% | 1.90M | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 76.90K | SH | $43.02M 4.37% | 76.90K | 0.00 | 0.00 |
REVVITY INCSOLE | COM | 299.09K | SH | $31.64M 3.21% | 299.09K | 0.00 | 0.00 |
HEALTHEQUITY INCSOLE | COM | 351.98K | SH | $31.10M 3.16% | 351.98K | 0.00 | 0.00 |
INSPIRE MED SYS INCSOLE | COM | 186.43K | SH | $29.69M 3.02% | 186.43K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 547.12K | SH | $26.46M 2.69% | 547.12K | 0.00 | 0.00 |
COMMUNITY HEALTH SYS INC NEWSOLE | COM | 8.46M | SH | $22.84M 2.32% | 8.46M | 0.00 | 0.00 |
ZIMVIE INCSOLE | COM | 2.08M | SH | $22.46M 2.28% | 2.08M | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 1.41M | SH | $21.68M 2.20% | 1.41M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 557.07K | SH | $21.03M 2.14% | 557.07K | 0.00 | 0.00 |
BRUKER CORPSOLE | COM | 499.21K | SH | $20.84M 2.12% | 499.21K | 0.00 | 0.00 |
CENTENE CORP DELSOLE | COM | 340.34K | SH | $20.66M 2.10% | 340.34K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 1.38M | SH | $18.57M 1.89% | 1.38M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 167.24K | SH | $18.50M 1.88% | 167.24K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 57.49K | SH | $17.72M 1.80% | 57.49K | 0.00 | 0.00 |
BIO-TECHNE CORPSOLE | COM | 280.12K | SH | $16.42M 1.67% | 280.12K | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 2.17M | SH | $16.29M 1.65% | 2.17M | 0.00 | 0.00 |
GLAUKOS CORPSOLE | COM | 158.96K | SH | $15.64M 1.59% | 158.96K | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 517.02K | SH | $15.60M 1.58% | 517.02K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 816.25K | SH | $14.63M 1.49% | 816.25K | 0.00 | 0.00 |
Page 1 of 3